| Topics covered in this issue..! |
|
|
|
|
|
|
München 80335, Bayern, Oberbayern, Germany
Next Generation Sequencing (NGS) technology has enabled researchers to generate genome wide data in unprecedented quality and quantity.
|
|
|
|
|
|
|
|
|
|
Date: 13th– 14th Aug 2025
Venue: Boston, MA
|
|
|
Date: 7th– 9th Oct 2025
Venue: Boston, MA
|
|
|
Date: 7th– 8th Jul 2025
Venue: Swizerland
|
|
|
|
Interested in publicizing your event in the next issue e-newsletter? Write to Us
|
|
|
|
|
|
|
Incyte announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi® (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody..
|
|
|
PanOptix Pro leverages proprietary ENLIGHTEN® NXT Optical technology which delivers the lowest light scatter and highest reported light utilization of any trifocal IOL....
|
|
|
STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd...
|
|
|
Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials.
|
|
|
|
|
|
|
|
|
The new offering is specially designed for prefilled syringes used in various applications, including ophthalmic intravitreal injections.
|
|
|
|
Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced it has launched Leuprolide Acetate Injection in the United States.
|
|
In order to educate our audience about, 'New discoveries' or 'Product Launches', they can be published online under the Innovations section.
— To promote product launches in next issue e-Newsletter, Write to us.
|
|
|
|
|
